Sign In

Login

Password

Forgot Password ? Sign Up

Контрольована гіперстимуляція яєчників (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Контрольована гіперстимуляція яєчників" in Ukrainian language version.

refsWebsite
Global rank Ukrainian rank
32nih.gov
4th place
5th place
26doi.org
2nd place
4th place
7web.archive.org
1st place
1st place
3worldcat.org
5th place
9th place
1thefreedictionary.com
614th place
611th place
1yourdictionary.com
4,339th place
2,028th place
1advancedfertility.com
low place
low place
1nice.org.uk
3,258th place
2,376th place
1northwestern.edu
2,302nd place
5,007th place
1mft.nhs.uk
low place
low place
1sst.dk
low place
low place

advancedfertility.com

doi.org

  • Reply: The two sides of the individualization of controlled ovarian stimulation. Human Reproduction Update. 20 (4): 614—5. Jul–Aug 2014. doi:10.1093/humupd/dmu014. PMID 25093217.
  • La Marca A, Sunkara SK (2013). Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update. 20 (1): 124—40. doi:10.1093/humupd/dmt037. PMID 24077980.
  • Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL (2011). The poor responder in IVF: is the prognosis always poor?: a systematic review. Human Reproduction Update. 18 (1): 1—11. doi:10.1093/humupd/dmr037. PMID 21987525.
  • Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ (Jan–Feb 2010). AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update. 17 (1): 46—54. doi:10.1093/humupd/dmq034. PMID 20667894.
  • Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I (November 2009). Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertility and Sterility. 92 (5): 1586—93. doi:10.1016/j.fertnstert.2008.08.127. PMID 18930213.
  • van der Stege JG, van der Linden PJ (Sep 2001). Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization. Gynecologic and Obstetric Investigation. Karger. 52 (1): 43—6. doi:10.1159/000052939. PMID 11549863.
  • Harris ID, Missmer SA, Hornstein MD (June 2010). Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women. Fertility and Sterility. 94 (1): 144—8. doi:10.1016/j.fertnstert.2009.02.040. PMID 19394605.
  • He M, Zhao L, Powell WB (July 2010). Optimal control of dosage decisions in controlled ovarian hyperstimulation. Annals of Operations Research. 178 (1): 223—45. doi:10.1007/s10479-009-0563-y.
  • Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J (July 2015). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 7 (7): CD010537. doi:10.1002/14651858.CD010537.pub4. PMID 26174592.
  • Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJ, Hughes EG, Macklon NS, Broekmans FJ, Fauser BC (2010). Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Human Reproduction Update. 17 (2): 184—96. doi:10.1093/humupd/dmq041. PMID 20843965.
  • Pouwer AW, Farquhar C, Kremer JA (July 2015). Long-acting FSH versus daily FSH for women undergoing assisted reproduction. The Cochrane Database of Systematic Reviews. 7 (7): CD009577. doi:10.1002/14651858.CD009577.pub3. PMID 26171903.
  • Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A, Borges E (June 2010). Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression. Fertility and Sterility. 94 (1): 167—72. doi:10.1016/j.fertnstert.2009.02.075. PMID 19342035.
  • Kamath, MS; Maheshwari, A; Bhattacharya, S; Lor, KY; Gibreel, A (2 листопада 2017). Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. The Cochrane Database of Systematic Reviews. 11: CD008528. doi:10.1002/14651858.CD008528.pub3. PMC 6486039. PMID 29096046.
  • Teixeira DM, Martins WP (Jul–Aug 2014). The two sides of the individualization of controlled ovarian stimulation. Human Reproduction Update. 20 (4): 614. doi:10.1093/humupd/dmu013. PMID 24643343.
  • Mochtar, MH; Danhof, NA; Ayeleke, RO; Van der Veen, F; van Wely, M (24 травня 2017). Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. The Cochrane Database of Systematic Reviews. 5: CD005070. doi:10.1002/14651858.CD005070.pub3. PMC 6481753. PMID 28537052.
  • Farquhar, Cindy; Marjoribanks, Jane (17 серпня 2018). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 8: CD010537. doi:10.1002/14651858.CD010537.pub5. ISSN 1469-493X. PMC 6953328. PMID 30117155.
  • Sivalingam VN, Myers J, Nicholas S, Balen AH, Crosbie EJ (Nov–Dec 2014). Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Human Reproduction Update. 20 (6): 853—68. doi:10.1093/humupd/dmu037. PMID 25013215.
  • Copperman AB, Benadiva C (March 2013). Optimal usage of the GnRH antagonists: a review of the literature. Reproductive Biology and Endocrinology. 11 (1): 20. doi:10.1186/1477-7827-11-20. PMC 3618003. PMID 23496864.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
  • Siristatidis, Charalampos S; Gibreel, Ahmed; Basios, George; Maheshwari, Abha; Bhattacharya, Siladitya (2015). Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews (11): CD006919. doi:10.1002/14651858.CD006919.pub4. ISSN 1465-1858. PMID 26558801.
  • Park, Chan Woo; Hwang, Yu Im; Koo, Hwa Seon; Kang, Inn Soo; Yang, Kwang Moon; Song, In Ok (2014). Early gonadotropin-releasing hormone antagonist start improves follicular synchronization and pregnancy outcome as compared to the conventional antagonist protocol. Clinical and Experimental Reproductive Medicine. 41 (4): 158—164. doi:10.5653/cerm.2014.41.4.158. ISSN 2233-8233. PMC 4295942. PMID 25599038.
  • Humaidan P, Kol S, Papanikolaou EG (2011). GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Human Reproduction Update. 17 (4): 510—24. doi:10.1093/humupd/dmr008. PMID 21450755.
  • Farquhar, C; Marjoribanks, J (17 серпня 2018). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 8: CD010537. doi:10.1002/14651858.CD010537.pub5. PMC 6513476. PMID 30117155.
  • Kwan I, Bhattacharya S, Kang A, Woolner A (August 2014). Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). The Cochrane Database of Systematic Reviews (8): CD005289. doi:10.1002/14651858.CD005289.pub3. PMC 6464819. PMID 25150465.
  • Raine-Fenning N, Deb S, Jayaprakasan K, Clewes J, Hopkisson J, Campbell B (June 2010). Timing of oocyte maturation and egg collection during controlled ovarian stimulation: a randomized controlled trial evaluating manual and automated measurements of follicle diameter. Fertility and Sterility. 94 (1): 184—8. doi:10.1016/j.fertnstert.2009.02.063. PMID 19342014.
  • Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET (2012). Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Human Reproduction Update. 19 (2): 105—23. doi:10.1093/humupd/dms051. PMID 23255514.
  • Sergentanis TN, Diamantaras AA, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET (2013). IVF and breast cancer: a systematic review and meta-analysis. Human Reproduction Update. 20 (1): 106—23. doi:10.1093/humupd/dmt034. PMID 23884897.

mft.nhs.uk

nice.org.uk

guidance.nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Reply: The two sides of the individualization of controlled ovarian stimulation. Human Reproduction Update. 20 (4): 614—5. Jul–Aug 2014. doi:10.1093/humupd/dmu014. PMID 25093217.
  • La Marca A, Sunkara SK (2013). Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update. 20 (1): 124—40. doi:10.1093/humupd/dmt037. PMID 24077980.
  • Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL (2011). The poor responder in IVF: is the prognosis always poor?: a systematic review. Human Reproduction Update. 18 (1): 1—11. doi:10.1093/humupd/dmr037. PMID 21987525.
  • Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ (Jan–Feb 2010). AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update. 17 (1): 46—54. doi:10.1093/humupd/dmq034. PMID 20667894.
  • Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I (November 2009). Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertility and Sterility. 92 (5): 1586—93. doi:10.1016/j.fertnstert.2008.08.127. PMID 18930213.
  • van der Stege JG, van der Linden PJ (Sep 2001). Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization. Gynecologic and Obstetric Investigation. Karger. 52 (1): 43—6. doi:10.1159/000052939. PMID 11549863.
  • Harris ID, Missmer SA, Hornstein MD (June 2010). Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women. Fertility and Sterility. 94 (1): 144—8. doi:10.1016/j.fertnstert.2009.02.040. PMID 19394605.
  • Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J (July 2015). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 7 (7): CD010537. doi:10.1002/14651858.CD010537.pub4. PMID 26174592.
  • Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJ, Hughes EG, Macklon NS, Broekmans FJ, Fauser BC (2010). Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Human Reproduction Update. 17 (2): 184—96. doi:10.1093/humupd/dmq041. PMID 20843965.
  • Pouwer AW, Farquhar C, Kremer JA (July 2015). Long-acting FSH versus daily FSH for women undergoing assisted reproduction. The Cochrane Database of Systematic Reviews. 7 (7): CD009577. doi:10.1002/14651858.CD009577.pub3. PMID 26171903.
  • Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A, Borges E (June 2010). Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression. Fertility and Sterility. 94 (1): 167—72. doi:10.1016/j.fertnstert.2009.02.075. PMID 19342035.
  • Kamath, MS; Maheshwari, A; Bhattacharya, S; Lor, KY; Gibreel, A (2 листопада 2017). Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. The Cochrane Database of Systematic Reviews. 11: CD008528. doi:10.1002/14651858.CD008528.pub3. PMC 6486039. PMID 29096046.
  • Teixeira DM, Martins WP (Jul–Aug 2014). The two sides of the individualization of controlled ovarian stimulation. Human Reproduction Update. 20 (4): 614. doi:10.1093/humupd/dmu013. PMID 24643343.
  • Mochtar, MH; Danhof, NA; Ayeleke, RO; Van der Veen, F; van Wely, M (24 травня 2017). Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. The Cochrane Database of Systematic Reviews. 5: CD005070. doi:10.1002/14651858.CD005070.pub3. PMC 6481753. PMID 28537052.
  • Farquhar, Cindy; Marjoribanks, Jane (17 серпня 2018). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 8: CD010537. doi:10.1002/14651858.CD010537.pub5. ISSN 1469-493X. PMC 6953328. PMID 30117155.
  • Sivalingam VN, Myers J, Nicholas S, Balen AH, Crosbie EJ (Nov–Dec 2014). Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Human Reproduction Update. 20 (6): 853—68. doi:10.1093/humupd/dmu037. PMID 25013215.
  • Copperman AB, Benadiva C (March 2013). Optimal usage of the GnRH antagonists: a review of the literature. Reproductive Biology and Endocrinology. 11 (1): 20. doi:10.1186/1477-7827-11-20. PMC 3618003. PMID 23496864.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
  • Siristatidis, Charalampos S; Gibreel, Ahmed; Basios, George; Maheshwari, Abha; Bhattacharya, Siladitya (2015). Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews (11): CD006919. doi:10.1002/14651858.CD006919.pub4. ISSN 1465-1858. PMID 26558801.
  • Park, Chan Woo; Hwang, Yu Im; Koo, Hwa Seon; Kang, Inn Soo; Yang, Kwang Moon; Song, In Ok (2014). Early gonadotropin-releasing hormone antagonist start improves follicular synchronization and pregnancy outcome as compared to the conventional antagonist protocol. Clinical and Experimental Reproductive Medicine. 41 (4): 158—164. doi:10.5653/cerm.2014.41.4.158. ISSN 2233-8233. PMC 4295942. PMID 25599038.
  • Humaidan P, Kol S, Papanikolaou EG (2011). GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Human Reproduction Update. 17 (4): 510—24. doi:10.1093/humupd/dmr008. PMID 21450755.
  • Farquhar, C; Marjoribanks, J (17 серпня 2018). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Database of Systematic Reviews. 8: CD010537. doi:10.1002/14651858.CD010537.pub5. PMC 6513476. PMID 30117155.
  • Kwan I, Bhattacharya S, Kang A, Woolner A (August 2014). Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). The Cochrane Database of Systematic Reviews (8): CD005289. doi:10.1002/14651858.CD005289.pub3. PMC 6464819. PMID 25150465.
  • Raine-Fenning N, Deb S, Jayaprakasan K, Clewes J, Hopkisson J, Campbell B (June 2010). Timing of oocyte maturation and egg collection during controlled ovarian stimulation: a randomized controlled trial evaluating manual and automated measurements of follicle diameter. Fertility and Sterility. 94 (1): 184—8. doi:10.1016/j.fertnstert.2009.02.063. PMID 19342014.
  • Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET (2012). Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Human Reproduction Update. 19 (2): 105—23. doi:10.1093/humupd/dms051. PMID 23255514.
  • Sergentanis TN, Diamantaras AA, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET (2013). IVF and breast cancer: a systematic review and meta-analysis. Human Reproduction Update. 20 (1): 106—23. doi:10.1093/humupd/dmt034. PMID 23884897.

ncbi.nlm.nih.gov

northwestern.edu

oncofertility.northwestern.edu

sst.dk

thefreedictionary.com

medical-dictionary.thefreedictionary.com

web.archive.org

worldcat.org

search.worldcat.org

yourdictionary.com